0·03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial
Version of Record online: 19 MAR 2004
British Journal of Dermatology
Volume 150, Issue 3, pages 554–562, March 2004
How to Cite
Reitamo, S., Harper, J., Bos, J.D., Cambazard, F., Bruijnzeel-Koomen, C., Valk, P., Smith, C., Moss, C., Dobozy, A., Palatsi, R. and The European Tacrolimus Ointment Group (2004), 0·03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. British Journal of Dermatology, 150: 554–562. doi: 10.1046/j.1365-2133.2004.05782.x
- Issue online: 19 MAR 2004
- Version of Record online: 19 MAR 2004
- Accepted for publication 4 August 2003
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.